Zylox-Tonbridge Medical Technology. 

€1.37
0
+€0+0% Tuesday 08:15

통계

낮 최고
1.39
낮음
1.37
52W 높음
-
52W 낮음
-
거래량
0
평균 거래량
-
시가 총액
448M
주가수익률
137
배당수익률
-
배당금
-

예정

수익

19Aug예상
Q4 2023
Q2 2024
0.03
0.36
0.69
1.03
예상 EPS
해당 없음
실제 EPS
0.026368274575

다른 인물도 팔로우하고 있습니다

이 목록은 Stock Events에서 818.F을(를) 팔로우하는 사람들의 워치리스트에 기반한 것입니다. 이는 투자 권유가 아닙니다.

경쟁자

이 목록은 최근 시장 이벤트에 기반한 분석입니다. 투자 권장사항이 아닙니다.

개요

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
CEO
Dr. Zhong Zhao
직원
756
국가
CN
ISIN
CNE100004JD2
WKN
000A3CS7H

목록